Aine Clements
Aine Clements has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Angeles Alvarez Secord
Duke Cancer Institute 5 Durham, NC
2 shared publications - Ann H. Klopp
MD Anderson Cancer Center, Houston, TX, United States of America
2 shared publications - Casey M. Cosgrove
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Ohio State University College of Medicine, Columbus, OH, USA
2 shared publications - Danielle Enserro
NRG Oncology, CTDD Biostatistics & Bioinformatics; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA
2 shared publications - David E. Cohn
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA
2 shared publications - David Warshal
Cooper Hospital/University Medical Center, Camden, NJ, United States of America
2 shared publications
Latest Publications
- Open Access
- 26 May 2026
- Published by Elsevier in Gynecologic Oncology
- Vol. 210, 63-71
Molecular classification and association with survival outcomes in high-intermediate and high-risk early-stage endometrial cancers: Ancillary analysis of GOG-0249
- 26 May 2026
- Published by Elsevier in Gynecologic Oncology
- Vol. 210, 63-71
Open AccessMolecular classification and association with survival outcomes in high-intermediate and high-risk early-stage endometrial cancers: Ancillary analysis of GOG-0249
- Top Cited Papers
- 23 January 2025
- Published by Elsevier in Gynecologic Oncology
- Vol. 193, 119-129
Molecular classification of endometrial cancers (EC) and association with relapse-free survival (RFS) and overall survival (OS) outcomes: Ancillary analysis of GOG-0258
- 23 January 2025
- Published by Elsevier in Gynecologic Oncology
- Vol. 193, 119-129
Top Cited PapersMolecular classification of endometrial cancers (EC) and association with relapse-free survival (RFS) and overall survival (OS) outcomes: Ancillary analysis of GOG-0258
- Open Access
- 1 January 2025
- Published by Wiley in Case Reports in Obstetrics and Gynecology
- Vol. 2025 (1) , 1319978
Treatment of Ovarian Clear Cell Carcinoma: A Case of Successful Management With Targeted Therapies
Background: Advanced stages of ovarian clear cell carcinoma have poorer prognoses than many other ovarian cancers. When standard treatments are ineffective, alternative options are needed. Case: A 56‐year‐old woman was diagnosed with ovarian clear cell carcinoma and treated with surgical management as well as carboplatin and paclitaxel. At recurrence, her disease progressed despite multiple chemotherapy regimens. A durable response was achieved first with alpelisib, chosen based on genomic testing. When progression occurred on this agent, a partial disease response was achieved with the combination of nivolumab and ipilimumab. Conclusion: The use of targeted therapies as well as the combination of nivolumab and ipilimumab is a promising option in advanced and recurrent cases of ovarian clear cell carcinoma.
- 1 January 2025
- Published by Wiley in Case Reports in Obstetrics and Gynecology
- Vol. 2025 (1) , 1319978
Open AccessTreatment of Ovarian Clear Cell Carcinoma: A Case of Successful Management With Targeted Therapies
Background: Advanced stages of ovarian clear cell carcinoma have poorer prognoses than many other ovarian cancers. When standard treatments are ineffective, alternative options are needed. Case: A 56‐year‐old woman was diagnosed with ovarian clear cell carcinoma and treated with surgical management as well as carboplatin and paclitaxel. At recurrence, her disease progressed despite multiple chemotherapy regimens. A durable response was achieved first with alpelisib, chosen based on genomic testing. When progression occurred on this agent, a partial disease response was achieved with the combination of nivolumab and ipilimumab. Conclusion: The use of targeted therapies as well as the combination of nivolumab and ipilimumab is a promising option in advanced and recurrent cases of ovarian clear cell carcinoma.
- 1 November 2020
- Published by Elsevier in Gynecologic Oncology
- Vol. 159 (2) , 498-502
A cost-effectiveness analysis of sentinel lymph node detection in vulvar cancer by preoperative lymphoscintigraphy versus intraoperative detection alone
- 1 November 2020
- Published by Elsevier in Gynecologic Oncology
- Vol. 159 (2) , 498-502
A cost-effectiveness analysis of sentinel lymph node detection in vulvar cancer by preoperative lymphoscintigraphy versus intraoperative detection alone
- Open Access
- 1 August 2015
- Published by Elsevier in Gynecologic Oncology Reports
- Vol. 13, 26-29
WWP2 and its association with PTEN in endometrial cancer
- 1 August 2015
- Published by Elsevier in Gynecologic Oncology Reports
- Vol. 13, 26-29
Open AccessWWP2 and its association with PTEN in endometrial cancer
- 1 December 2013
- Published by Elsevier in Gynecologic Oncology
- Vol. 131 (3) , 508-511
Reducing readmissions after robotic surgical management of endometrial cancer:A potential for improved quality care
- 1 December 2013
- Published by Elsevier in Gynecologic Oncology
- Vol. 131 (3) , 508-511
Reducing readmissions after robotic surgical management of endometrial cancer:A potential for improved quality care